1. Home
  2. AVTX vs RBKB Comparison

AVTX vs RBKB Comparison

Compare AVTX & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • RBKB
  • Stock Information
  • Founded
  • AVTX 2011
  • RBKB 1860
  • Country
  • AVTX United States
  • RBKB United States
  • Employees
  • AVTX N/A
  • RBKB N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • RBKB Banks
  • Sector
  • AVTX Health Care
  • RBKB Finance
  • Exchange
  • AVTX Nasdaq
  • RBKB Nasdaq
  • Market Cap
  • AVTX 138.8M
  • RBKB 139.1M
  • IPO Year
  • AVTX 2015
  • RBKB 2019
  • Fundamental
  • Price
  • AVTX $13.50
  • RBKB $11.56
  • Analyst Decision
  • AVTX Strong Buy
  • RBKB
  • Analyst Count
  • AVTX 9
  • RBKB 0
  • Target Price
  • AVTX $30.14
  • RBKB N/A
  • AVG Volume (30 Days)
  • AVTX 451.4K
  • RBKB 6.4K
  • Earning Date
  • AVTX 11-06-2025
  • RBKB 10-23-2025
  • Dividend Yield
  • AVTX N/A
  • RBKB N/A
  • EPS Growth
  • AVTX N/A
  • RBKB N/A
  • EPS
  • AVTX N/A
  • RBKB N/A
  • Revenue
  • AVTX $441,000.00
  • RBKB $31,018,000.00
  • Revenue This Year
  • AVTX N/A
  • RBKB N/A
  • Revenue Next Year
  • AVTX N/A
  • RBKB N/A
  • P/E Ratio
  • AVTX N/A
  • RBKB N/A
  • Revenue Growth
  • AVTX N/A
  • RBKB N/A
  • 52 Week Low
  • AVTX $3.39
  • RBKB $8.81
  • 52 Week High
  • AVTX $16.00
  • RBKB $13.99
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 65.78
  • RBKB 40.29
  • Support Level
  • AVTX $12.41
  • RBKB $11.07
  • Resistance Level
  • AVTX $14.73
  • RBKB $11.99
  • Average True Range (ATR)
  • AVTX 0.94
  • RBKB 0.29
  • MACD
  • AVTX 0.13
  • RBKB -0.03
  • Stochastic Oscillator
  • AVTX 70.97
  • RBKB 29.35

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one-to four-family residential real estate loans, and to purchase investment securities.

Share on Social Networks: